Stockreport

FDA OKs J&J's Balversa for bladder cancer [Seeking Alpha]

IMMUNOMEDICS  (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF FDA OKs J&J's Balversa for bladder cancer Under accelerated review status, the FDA approves JNJ +0.2% Immunomedics ( IMMU +0.4% detailing services The agency also approv [Read more]